Regulation of hTERT by BCR-ABL at multiple levels in K562 cells

BACKGROUND: The cytogenetic characteristic of Chronic Myeloid Leukemia (CML) is the formation of the Philadelphia chromosome gene product, BCR-ABL. Given that BCR-ABL is the specific target of Gleevec in CML treatment, we investigated the regulation of the catalytic component of telomerase, hTERT, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Juin Hsien, Zhang, Yong, Tan, Wei Han, Chng, Wee Joo, Li, Baojie, Wang, Xueying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259104/
https://www.ncbi.nlm.nih.gov/pubmed/22151181
http://dx.doi.org/10.1186/1471-2407-11-512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259104/
https://www.ncbi.nlm.nih.gov/pubmed/22151181
http://dx.doi.org/10.1186/1471-2407-11-512

Ejemplares similares